![Logo of OpenAlex.org Project OpenAlex Citations Logo](https://www.oahelper.org/wp-content/plugins/oahelper-citations/img/logo-openalex.jpg)
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Inhibitors to degraders: Changing paradigm in drug discovery
V. Haridas, Souvik Dutta, Akshay Munjal, et al.
iScience (2024) Vol. 27, Iss. 5, pp. 109574-109574
Open Access | Times Cited: 6
V. Haridas, Souvik Dutta, Akshay Munjal, et al.
iScience (2024) Vol. 27, Iss. 5, pp. 109574-109574
Open Access | Times Cited: 6
Showing 6 citing articles:
Degrading Mutant IDH1 Employing a PROTAC-Based Approach Impairs STAT3 Activation
Hashnu Dutta, Nishant Jain
Archives of Biochemistry and Biophysics (2025), pp. 110281-110281
Closed Access
Hashnu Dutta, Nishant Jain
Archives of Biochemistry and Biophysics (2025), pp. 110281-110281
Closed Access
Discovery of the First Potent ROR1 Degrader for the Treatment of Non-Small Cell Lung Cancer
Jinlin Li, Lin Li, Hou Cai-yun, et al.
European Journal of Medicinal Chemistry (2025), pp. 117325-117325
Closed Access
Jinlin Li, Lin Li, Hou Cai-yun, et al.
European Journal of Medicinal Chemistry (2025), pp. 117325-117325
Closed Access
Targeted Protein Degradation (TPD) for Immunotherapy: Understanding Proteolysis Targeting Chimera-Driven Ubiquitin-Proteasome Interactions
Rajamanikkam Kamaraj, Subhrojyoti Ghosh, Souvadra Das, et al.
Bioconjugate Chemistry (2024) Vol. 35, Iss. 8, pp. 1089-1115
Open Access | Times Cited: 3
Rajamanikkam Kamaraj, Subhrojyoti Ghosh, Souvadra Das, et al.
Bioconjugate Chemistry (2024) Vol. 35, Iss. 8, pp. 1089-1115
Open Access | Times Cited: 3
Discovery of the First Potent Ror1 Degrader for the Treatment of Non-Small Cell Lung Cancer
Fengtao Zhou, Jinlin Li, Lin Li, et al.
(2024)
Closed Access
Fengtao Zhou, Jinlin Li, Lin Li, et al.
(2024)
Closed Access
Targeted protein degradation: expanding the technology to facilitate the clearance of neurotoxic proteins in neurodegenerative diseases
Xin Wang, Shuai Wen, Panpan Yang, et al.
Ageing Research Reviews (2024), pp. 102584-102584
Closed Access
Xin Wang, Shuai Wen, Panpan Yang, et al.
Ageing Research Reviews (2024), pp. 102584-102584
Closed Access
Eliminating Aggressive Cancers via PROTAC-like Inducers of Ferroptosis
Avital Oknin-Vaisman, Deepanjan Panda, Rostislav Novak, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Avital Oknin-Vaisman, Deepanjan Panda, Rostislav Novak, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access